• Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
    • Mergers & Acquisitions
  • Value-based Care

Roche Acquires Rest of Foundational Medicine for $2.4B to Enhance Precision Medicine

by Jasmine Pennic 06/19/2018 Leave a Comment

Share with your friends










Submit

Roche Acquires Rest of Foundational Medicine for $2.4B to Enhance Precision Medicine

Roche, today announced it has acquire all of the outstanding shares in Foundation Medicine that is not already owned by Roche and its affiliates for $2.4B, representing $137 per share. Together, the companies will leverage expertise in genomics and molecular information to enhance the development of perdsonalized medicines and care for patients with cancer.

Foundation Medicine, based in Cambridge, Massachusetts, is a market leading molecular information company dedicated to a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease. Their services include a full suite of comprehensive genomic profiling (CGP) assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials.

Upon closing, the acquisition focuses on integrating Foundation Medicine’s high quality comprehensive genomic profiling (CGP) testing and innovative data services to realise Roche’s vision of personalized healthcare. Foundation Medicine (FMI) will continue its operations as a separate and autonomous legal entity.

“Foundation Medicine and Roche share the philosophy that every cancer patient should have access to personalized care informed by validated molecular information. Joining forces with Roche as an independent operating company allows Foundation Medicine to continue its collaboration with Roche, as well as our biopharma partners, to drive ubiquitous access to CGP testing and innovative data services,” said Troy Cox, Chief Executive Officer for Foundation Medicine.

The acquisition is expected to take place in the second half of 2018.

Tagged With: Cancer Genomics, foundational, genomic precision medicine, Healthcare Mergers & Aquisitions, Precision Medicine Oncology, Roche

Share with your friends










Submit

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Qardio Integrates Remote Monitoring Solution with Greenway Health EHR Solution
Partners Healthcare Taps Circulation to Bring On-Demand Medical Transportation to Patients »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • Bayer and Geisinger to Create EHR-Integrated Contraception Counseling Pathway

    Bayer and Geisinger to Create EHR-Integrated Contraception Counseling Pathway

    B... more
  • GHX Names Top 50 Healthcare Providers for Supply Chain Excellence

    GHX Names Top 50 Healthcare Providers for Supply Chain Excellence

    G... more
  • 4 Trends We Expect to See at HIMSS 2019

    HIMSS19 Day 4 Announcements & Summary

    H... more

Most Read

  • 4 Trends We Expect to See at HIMSS 2019 HIMSS19 Day 4 Announcements & Summary
  • Healthcare Breach Report 2016 6 Ways Health Informatics Is Transforming Health Care
  • Business Models In Healthcare 12 Defining Healthcare Trends to Watch in 2018
  • Bayer and Geisinger to Create EHR-Integrated Contraception Counseling Pathway Bayer and Geisinger to Create EHR-Integrated Contraception Counseling Pathway
  • Canada ICD-10 Transition 20 Promising Canadian Digital Health Companies to Watch
  • Top 10 Challenges, Issues and Opportunities for Healthcare Executives in 2019 Top 10 Challenges, Issues and Opportunities for Healthcare Executives in 2019
  • Applying Automation to Healthcare_Is the Phrase Patient Engagement Overused 6 Big Benefits of Applying Automation to Healthcare
  • 4 Trends We Expect to See at HIMSS 2019 HIMSS19 Day 2 Announcements & Summary
  • The State of Value-based Care in 2018: 10 Key Trends to Know The State of Value-based Care in 2018: 10 Key Trends to Know
  • 4 Trends We Expect to See at HIMSS 2019 HIMSS19 Day 1 Announcements & Summary

Company

  • About Us
  • Advertise with Us
  • 2019 Editorial Calendar
  • Media Kit
  • Contributor Network
  • Contact
  • Subscribe

Editorial Coverage

  • Health IT
  • Policy
  • mHealth
  • Digital Health
  • Startups
  • Infographics

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2019. HIT Consultant Media. All Rights Reserved. Privacy Policy |